KENS 5: Remdesivir study underway by UT Health San Antonio and University Health System

Dr. Thomas Patterson, Infectious Diseases, informs KENS 5 audiences about the three phases of the remdesivir trial, currently underway by UT Health San Antonio and University Health System. The FDA approval of the drug last week leads to fewer restrictions than the study had previously encountered under emergency-use authorization.

Read and watch the story.



Share This Article!
Article Categories: In the News

Recent News